Vitamin B1 mega dose for PD
PD meds in clinical trial (infographic)
Radical new therapy for Parkinson’s will use stem cell transplants
Lab-grown nerve cells will replace those destroyed by disease – scientists hope treatment may be available in five years
Source: Radical new therapy for Parkinson’s will use stem cell transplants
Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application – PMC
Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
Repurposing anti-diabetic drugs for the treatment of Parkinson’s disease
The most pressing need in Parkinson’s disease (PD) clinical practice is to identify agents that might slow down, stop or reverse the neurodegenerative process of Parkinson’s disease and therefore avoid the onset of the most disabling, dopa-refractory symptoms of the disease. These include dementia, …
Reduce brain inflammation
The ROOT CAUSES Of Alzheimer’s Disease & How To PREVENT IT | Dr. Dale Bredesen
The Huberman podcast
Parkinson – List Results – ClinicalTrials.gov
Ketogenic therapies for lymphedema
elevation of lymph ketone body levels by a high-fat, low-carbohydrate ketogenic diet or by administration of the ketone body β-hydroxybutyrate increases lymphangiogenesis – www.nature.com/articles/s42255-019-0087-y
from the lab – vib.be/news/using-ketone-bodies-fight-against-lymphedema
c.dif as possible cause of PD and other neurological diseases
10 Health Benefits of Low-Carb and Ketogenic Diets
Many studies show that low-carb and ketogenic diets can lead to dramatic weight loss and improve most major risk factors for heart disease and diabetes. Also, repeatedly shown (but not always) to help with or reverse PD and other neurologicsal conditions
SelfHacked – Home
SelfHacked is dedicated to supporting your health journey by providing you with the most cutting-edge, evidence-based information. Join our community of health hackers today and start improving your wellness.
Source: SelfHacked – Home
The quest for a disease-modifying drug for Parkinson’s disease continues – Drug Discovery and Development
The need for therapies that change the course of Parkinson’s disease is considerable. Several contenders are in development.
Ending Parkinson’s Disease: A Prescription for Action: Dorsey MD, Ray, Sherer PhD, Todd, Okun MD, Michael S., Bloem MD PhD, Bastiaan R.: 9781541724501: Amazon.com: Books
Therapeutic Effect of Hydrogen Sulfide-Releasing L-Dopa Derivative ACS84 on 6-OHDA-Induced Parkinson’s Disease Rat Model
Parkinson’s disease and basal ganglia calcifications: prevalence and clinico-radiological correlations – PubMed
We reviewed computerized tomograms (CT) for basal ganglia and dentate nucleus calcifications in 79 patients with Parkinson’s disease (PD), 54 patients with Alzheimer’s disease (AD) and 109 controls aged 50 or more. When it was determined, no patient had disturbances in calcium metabolism. We found: …